TRex Bio is a Biotech company based in South San Francisco, CA. It has raised $193M in total funding. Latest round: Series B.
TRex Bio is a Biotech company based in South San Francisco, CA. TRex Bio has raised $193M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in November 2024. The round record for TRex Bio runs through 2024; nothing later has been disclosed. Investors on record include Eli Lilly and Company, SV Health Investors, Johnson & Johnson Innovation, Pfizer Ventures, Alexandria Venture Investments, Janus Henderson Investors and 7 others. 13 distinct backers are named across the disclosed rounds.
Totals shown for TRex Bio aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in South San Francisco and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026